<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Herb/Milk_Thistle.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:32:20 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2130007">
<meta name="Category" content="Herb">
<meta name="Article" content="Milk_Thistle">
<title>Cardo Mariano-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Cardo Mariano</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Milk_Thistle.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Wagner H, Horhammer L, Munster R. The chemistry of silymarin (silybin), the
active principle of the fruits of <em>Silybum marianum</em> (L.) Gaertn. <em>Arzneim-Forsch
Drug Res</em> 1968;18:688&#8211;96.</li>

<li class="Ref">Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions of
flavonolignans from <em>Silybum marianum</em> fruits. <em>Planta Medica</em>
1984;50:248&#8211;50.</li>

<li class="Ref">Faulstich H, Jahn W, Wieland T. Silibinin inhibition of amatoxin uptake in the
perfused rat liver. <em>Arzneim-Forsch Drug Res</em> 1980;30:452&#8211;4.</li>

<li class="Ref">Tuchweber B, Sieck R, Trost W. Prevention by silibinin of phalloidin induced
hepatotoxicity. <em>Toxicol Appl Pharmacol</em> 1979;51:265&#8211;75.</li>

<li class="Ref">Feher J, Lang I, Deak G, et al. Free radicals in tissue damage in liver
diseases and therapeutic approach. <em>Tokai J Exp Clin Med</em> 1986;11:121&#8211;34.</li>

<li class="Ref">Sonnenbichler J, Zetl I. Stimulating influence of a flavonolignan derivative
on proliferation, RNA synthesis and protein synthesis in liver cells. In <em>Assessment and
Management of Hepatobiliary Disease,</em> ed. L Okolicsanyi, G Csomos, G Crepaldi. Berlin:
Springer-Verlag, 1987, 265&#8211;72.</li>

<li class="Ref">Schuppan D, Str&#246;sser W, Burkard G, Walosek G. Legalon&#174; lessens
fibrosing activity in patients with chronic liver diseases. <em>Zeits Allgemeinmed</em>
1998;74:577&#8211;84.</li>

<li class="Ref">Salmi HA, Sama S. Effect of silymarin on chemical, functional and
morphological alterations of the liver. <em>Scand J Gastroenterol</em>
1982;17:517&#8211;21.</li>

<li class="Ref">Leng-Peschlow E. Alcohol-related liver diseases-use of Legalon&#174;. <em>Z
Klin Med</em> 1994;2:22&#8211;7.</li>

<li class="Ref">Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of
silymarin treatment in patients with cirrhosis of the liver. <em>J Hepatol</em>
1989;9:105&#8211;13.</li>

<li class="Ref">Velussi M, Cernogoi AM, De Monte A, et al. Long-term (12 months) treatment
with an antioxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need
and malondialdehyde levels in cirrhotic diabetic patients. <em>J Hepatology</em>
1997;26:871&#8211;9.</li>

<li class="Ref">Pares A, Plancs R, Torres M, et al. Effects of silymarin in alcoholic patients
with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter
trial. <em>J Hepatol</em> 1998;28:615&#8211;21.</li>

<li class="Ref">Nassuato G, Iemmolo RM, Strazzabosco M, et al. Effect of silibinin on biliary
lipid composition. Experimental and clinical study. <em>J Hepatol</em>
1991;12:290&#8211;5.</li>

<li class="Ref">Palasciano G, Portinascasa P, Palmieri V, et al. The effect of silymarin on
plasma levels of malondialdehyde in patients receiving long-term treatment with psychotropic
drugs. <em>Curr Ther Res</em> 1994;S5:S37&#8211;45.</li>

<li class="Ref">Allain H, Sch&#252;ck S, Lebreton S, et al. Aminotransferase levels and
silymarin in de novo tacrine-treated patients with Alzheimer&#8217;s disease. <em>Dementia
Geriatr Cogn Disorders</em> 1999;10:181&#8211;5.</li>

<li class="Ref">Brown DJ. <em>Herbal Prescriptions for Better Health.</em> Rocklin, CA: Prima
Publishing, 1996, 151&#8211;8.</li>

<li class="Ref">Reyes H. The spectrum of liver and gastrointestinal disease seen in
cholestasis of pregnancy. <em>Gastroert Clin N Am</em> 1992;21:905&#8211;21.</li>

<li class="Ref">Adverse Drug Reactions Advisory Committee. An adverse reaction to the herbal
medication milk thistle (<em>Silybum marianum</em>). <em>MJA</em> 1999;170:218&#8211;9.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Herb/Milk_Thistle.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:32:20 GMT -->
</html>

